S

S-Medicon Kft | Budapest, Hungary

Research site
(Unclaimed)
Location
47-49 Madarasz Viktor Street, Budapest, Budapest, Hungary
Site insights

Top conditions

Migraine Disorders (3 trials)

Top treatments

Atogepant
Topiramate

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 3
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migraine

This study will evaluate the Long-Term Safety and Tolerability of Atogepant 60 mg daily for the Prevention of Migraine in Participants with Chronic o...

Active, not recruiting
Chronic Migraine
Episodic Migraine
Drug: Atogepant 60 mg
Locations recently updated

A migraine is a moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vo...

Enrolling
Episodic Migraine
Drug: Atogepant
Drug: Placebo-Matching Atogepant
Locations recently updated

A migraine is a moderate to severe headache on one side of the head that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and...

Enrolling
Migraine
Drug: Placebo for Atogepant
Drug: Topiramate

Trial sponsors

AbbVie logo

AbbVie (3 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems